Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
192,975,286
-
Total 13F shares
-
181,117,177
-
Share change
-
-1,584,010
-
Total reported value
-
$12,795,609,480
-
Put/Call ratio
-
74%
-
Price per share
-
$70.69
-
Number of holders
-
576
-
Value change
-
-$83,582,224
-
Number of buys
-
334
-
Number of sells
-
221
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q1 2025
As of 31 Mar 2025,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
576 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
181,117,177 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, Dodge & Cox, VIKING GLOBAL INVESTORS LP, Capital Research Global Investors, STATE STREET CORP, AMERIPRISE FINANCIAL INC, Elliott Investment Management L.P., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
578
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.